Related Experiment Video
Updated: Mar 29, 2026
Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis
Published on: November 17, 2011
Optimized Protocol To Analyze Changes in the Lipidome of Xenografts after Treatment with 2-Hydroxyoleic Acid
Roberto Fernández1, Jone Garate1, Sergio Lage1
1Department of Physical Chemistry, Faculty of Science and Technology, University of the Basque Country (UPV/EHU) , Barrio Sarriena s/n, 48940 Leioa, Spain.
Abstract:
Xenografts are a popular model for the study of the action of new antitumor drugs. However, xenografts are highly heterogeneous structures, and therefore it is sometimes difficult to evaluate the effects of the compounds on tumor metabolism. In this context, imaging mass spectrometry (IMS) may yield the required information, due to its inherent characteristics of sensitivity and spatial resolution. To the best of our knowledge, there is still no clear analysis protocol to properly evaluate the changes between samples due to the treatment. Here we present a protocol for the evaluation of the effect of 2-hydroxyoleic acid (2-OHOA), an antitumor compound, on xenografts lipidome based on IMS. Direct treated/control comparison did not show conclusive results. As we will demonstrate, a more sophisticated protocol was required to evaluate these changes including the following: (1) identification of different areas in the xenograft, (2) classification of these areas (necrotic/viable) to compare similar types of tissues, (3) suppression of the effect of the variation of adduct formation between samples, and (4) normalization of the variables using the standard deviation to eliminate the excessive impact of the stronger peaks in the statistical analysis. In this way, the 36 lipid species that experienced the largest changes between treated and control were identified. Furthermore, incorporation of 2-hydroxyoleic acid to a sphinganine base was also confirmed by MS/MS. Comparison of the changes observed here with previous results obtained with different techniques demonstrates the validity of the protocol.
Insights
A new protocol using imaging mass spectrometry (IMS) effectively analyzes antitumor drug effects on xenograft lipidomes. This method precisely identifies metabolic changes, confirming 2-hydroxyoleic acid
Area of Science:
- Oncology
- Analytical Chemistry
- Biochemistry
Background:
- Xenografts are crucial for evaluating new antitumor drugs but present challenges in assessing compound effects on tumor metabolism due to heterogeneity.
- Existing methods struggle to precisely quantify metabolic alterations in xenograft models.
Purpose of the Study:
- To develop and validate a robust protocol for evaluating the impact of 2-hydroxyoleic acid (2-OHOA) on xenograft lipidomes using imaging mass spectrometry (IMS).
- To enable accurate comparison of treated and control xenograft samples by addressing inherent biological and technical variations.
Main Methods:
- Development of a sophisticated IMS analysis protocol involving area identification, tissue classification (necrotic/viable), adduct formation suppression, and standard deviation normalization.
- Application of the protocol to assess the effects of 2-hydroxyoleic acid (2-OHOA) on xenograft lipid profiles.
- Confirmation of 2-OHOA incorporation into sphinganine bases using MS/MS.
Main Results:
- The developed protocol successfully identified 36 lipid species with significant changes between treated and control xenografts.
- The study confirmed the incorporation of 2-hydroxyoleic acid into sphinganine bases, providing direct evidence of its metabolic activity.
- The protocol demonstrated superior ability to detect treatment-induced changes compared to direct sample comparisons.
Conclusions:
- The presented IMS-based protocol offers a reliable and sensitive method for analyzing drug-induced metabolic changes in heterogeneous xenograft models.
- This standardized approach enhances the evaluation of antitumor compounds by enabling precise lipidome profiling and comparison.
- The findings validate the protocol's utility and provide a foundation for future studies on drug efficacy and tumor metabolism.
